Overview
Anoro Ellipta is a prescription drug approved by the Food and Drug Administration (FDA) as long-term, once-daily maintenance treatment for airflow obstruction in people with chronic obstructive pulmonary disease (COPD). Anoro Ellipta is a combination drug composed of Umeclidinium and Vilanterol.

Umeclidinium is a long-acting anticholinergic drug. Vilanterol is an ultra-long-acting beta2 adrenoreceptor agonist (ultra-LABA). Both drugs are believed to work by relaxing smooth muscles in the airways.

How do I take it?
Anoro Ellipta is taken once daily by oral inhalation.

Anoro Ellipta comes in the form of foil blister pack containing powder. Anoro Ellipta is... read more

Anoro Ellipta (Umeclidinium/Vilanterol) Questions

MyCOPDTeam is a free social network that makes it easy to find others like you and gain insights from others living with COPD.
Sign up Log in